Latest Revenue Growth News

Centuria Office REIT has reported a strong half-year performance with a 56% increase in revenue and a significant turnaround to a $61.5 million net profit, while maintaining steady distributions.

Pinnacle Investment Management reported a robust 66.6% increase in revenues for the half year ended December 2025, yet profits and earnings per share declined, prompting a cautious outlook despite a healthy interim dividend.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.

Credit Corp Group posted a steady first half with 4% revenue growth and flat net profit, setting the stage for a robust second half driven by increased lending and debt buying investments.

Credit Corp Group Limited reported a steady half-year profit with a 4% revenue rise, driven by strong US collections and record lending volumes, while advancing its UK presence through a strategic acquisition.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.

JAYRIDE Group Limited advances its transformation into a scalable Mobility-as-a-Service platform with a new SaaS agreement in Thailand, strategic partnerships, and a successful capital raise. The company tightens its cost base while preparing for ASX reinstatement.

BPH Global has reported record sales in its Indonesian seaweed operations alongside completing a $1.1 million capital raise and advancing promising R&D projects. The company is scaling its trading platform and expanding into bio-stimulants and wellness products as it enters 2026.